DRDO Recruitment 2021: Year long ITI apprenticeship training offer open
August 10, 2021 18:45 ISTDRDO, Timarpur Delhi is looking for candidates to apply for ITI apprentice training for one year for 2021-22.
DRDO, Timarpur Delhi is looking for candidates to apply for ITI apprentice training for one year for 2021-22.
The test was carried out against a high-speed unmanned aerial target which was successfully intercepted by the missile.
The launch was witnessed by the representatives of the Indian Air Force. In order to capture flight data, ITR deployed a number of Range stations like, Electro-Optical Tracking System, Radar and Telemetry.
All the mission objectives were met. The missile (Man-Portable Anti-Tank Guided Missile) has been successfully flight-tested for the maximum range, DRDO said.
Defence Research and Development Organisation (DRDO) has developed a comprehensive solution to tackle the problem that drones may pose to national security agencies.
Agni-Prime is a short-range ballistic missile. It is a new generation advanced variant of the Agni class of missiles. It is a canisterised missile with a range capability between 1,000 and 2,000 kms.
2-deoxy-D-glucose (2DG) is an oral anti-viral drug for Covid-19 patients. The drug has generated a lot of curiosity after it was launched on May 17 by the Ministry of Defence.
As many as twenty-five rockets were launched in quick succession and the test met complete mission objectives, defence sources said.
A 500-bed COVID hospital set up using funds from PMCARES Fund has started admitting patients now.
2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy's Laboratories.
Of the total 500 beds at Bhagwati Nagar Centre, 125 would be Intensive Care Unit (ICU) beds, while others would be a set of Covid beds with 24 hours oxygen facility.
The Covid Care Centre has been dedicated and named after General Bipin Chandra Joshi, PVSM, AVSM, ADC who belonged to state of Uttarakhand and was the 17th Chief of Indian Army.
2-DG is an oral anti-viral drug for Covid-19 patients. It has been developed by the DRDO in collaboration with Dr Reddy's Laboratories. It reduces dependence on supplemental oxygen.
Of the total 500 beds here at Bhagwati Nagar Centre, 125 would be Intensive Care Unit beds, while others would be a set of Covid beds with 24 hours oxygen facility.
The price of DRDO’s 2DG anti-COVID 19 drug has been fixed at Rs 990 per sachet by Dr Reddy’s lab.
The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%.
India's first indigenous anti-COVID drug 2-DG is a "repurposed" medicine, the Indian Council of Medical Research said on Thursday. According to ICMR DG Dr. Balram Bhargava, the drug was earlier used for cancer treatment.
Dr Reddy's on Wednesday released important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories.
Haryana on Monday reported 114 COVID deaths and 7,488 fresh cases, taking the state’s fatality count to 6,799 and the total infection number to 7,01,915, according to a Health Department bulletin.
The first batch of 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 was released by Defence Minister Rajnath Singh on Monday. The medicine is being touted as a game-changer in the fight against COVID.
Top News
Latest News
